ePrivacy and GPDR Cookie Consent by TermsFeed Generator

XELJANZ

5MG TBL FLM 180

SÚKL code 0222097
Name of the product XELJANZ
_MA_MEDICATION_DETAIL_INFO_MED_NAME i XELJANZ
Supplement 5MG TBL FLM 180
Strenght 5MG
Pharmaceutical form Film-coated tablet
Package 180
Route Oral use
Wrap type Tablet container
Legal status na lékařský předpis
Active substance TOFACITINIB CITRATE (TOFACITINIBI CITRAS)
ATC group L04AA29
ATC group name TOFACITINIB

Marketing authorisation information

Registration Number EU/1/17/1178/002
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder Pfizer Europe MA EEIG, Bruxelles
MA Holder country BELGIE

Back to list